Calpain inhibitor MDL 28170 protects against the Ca2+ paradox in rat hearts
Authors:
- 22 February 2012
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 39 (4) , 385-392
Abstract
Summary: The calcium paradox represents an important model in which to study myocardial injuries due to intracellular Ca2+ overload. In a previous study, calpain was transiently activated in Ca2+‐paradoxic hearts. The aim of the present study was to determine the role of calpain in myocardial dysfunction in hearts subjected to the Ca2+ paradox and to elucidate the underlying mechanisms. Rat hearts were isolated, Langendorff perfused and subjected to the Ca2+ paradox, which was induced by 3 min Ca2+ depletion followed by 30 min Ca2+ repletion, in the presence or absence of the calpain inhibitor 10 umol/L MDL 28170. Cardiac function was evaluated. Furthermore, cell death and the degradation of troponin I (TnI) were assessed and calpain activity was determined by measurement of the α‐fodrin fragment and confocal image analysis. Upon Ca2+ repletion, the hearts immediately deteriorated, exhibiting a marked depression in cardiac function and an enlarged myocardial injury area. This was accompanied by significant increases in lactate dehydrogenase, mitochondrial release of cytochrome c, the apoptotic index and degraded TnI. These changes were significantly inhibited by MDL 28170, with the exception of TnI degradation. Compared with the control group, Ca2+‐paradoxic hearts showed a marked increase in cleaved 150 kDa fragments resulting from specific calpain‐mediated proteolysis of α‐fodrin. This effect was attenuated by MDL 28170. Confocal image analysis revealed the translocation of both μ‐ and m‐calpain to the sarcolemmal membrane in Ca2+‐paradoxic hearts, indicating increased activity of both isoforms. The results suggest that the Ca2+ paradox promotes calpain activity, leading to necrosis, apoptosis and myocardial dysfunction.Keywords
This publication has 37 references indexed in Scilit:
- Disruption of Rac1 signaling reduces ischemia–reperfusion injury in the diabetic heart by inhibiting calpainFree Radical Biology and Medicine, 2010
- Nuclear translocation of calpain‐2 regulates propensity toward apoptosis in cardiomyocytes of tail‐suspended ratsJournal of Cellular Biochemistry, 2010
- Ca2+paradox injury mediated through TRPC channels in mouse ventricular myocytesBritish Journal of Pharmacology, 2010
- Ischemia–reperfusion-induced changes in sarcolemmal Na+/K+-ATPase are due to the activation of calpain in the heartThis article is one of a selection of papers published in a Special Issue on Oxidative Stress in Health and Disease.Canadian Journal of Physiology and Pharmacology, 2010
- Calpain inhibition preserves myocardial structure and function following myocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Mitochondrial oxidative phosphorylation in hearts subjected to Ca2+ depletion and Ca2+ repletionThis article is one of a selection of papers published in a special issue celebrating the 125th anniversary of the Faculty of Medicine at the University of Manitoba.Canadian Journal of Physiology and Pharmacology, 2009
- Insulin inhibits myocardial ischemia-induced apoptosis and alleviates chronic adverse changes in post-ischemic cardiac structure and functionApoptosis, 2009
- Build it up-Tear it down: protein quality control in the cardiac sarcomereCardiovascular Research, 2008
- MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurineCardiovascular Research, 2006
- MDL-28170, a membrane-permeant calpain inhibitor, attenuates stunning and PKCε proteolysis in reperfused ferret heartsCardiovascular Research, 1997